Sinsin Pharmaceutical Co., Ltd (KOSDAQ: 002800)

Sinsin Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	3,071	346.46	2,240	799.33	2,504	1,130
Short-Term Investments	-	-	-	-	-	280
Cash & Short-Term Investments	3,071	346.46	2,240	799.33	2,504	1,410
Cash Growth	275.11%	-84.53%	180.24%	-68.08%	77.61%	-35.14%
Accounts Receivable	31,563	27,975	25,771	23,237	22,526	24,269
Other Receivables	2,992	2,216	1,953	1,652	1,479	1,538
Receivables	34,555	30,191	27,724	24,889	24,005	25,807
Inventory	15,341	15,733	14,390	10,370	12,371	12,966
Prepaid Expenses	201.51	160.45	34.91	33.79	70.89	30.73
Other Current Assets	899.87	676.95	659.08	375.07	729.2	4,376
Total Current Assets	54,069	47,108	45,048	36,467	39,680	44,589
Property, Plant & Equipment	66,103	68,264	66,825	69,345	70,034	80,219
Long-Term Investments	3,277	3,270	3,559	3,183	3,180	110.03
Other Intangible Assets	576.82	586.32	592.29	499.07	499.07	585.55
Long-Term Accounts Receivable	-0	-0	-0	-0	1.84	25.44
Long-Term Deferred Tax Assets	1,602	1,612	1,400	1,394	1,184	44.77
Other Long-Term Assets	3,601	3,570	3,790	3,418	3,555	3,664
Total Assets	129,229	124,409	121,213	114,307	118,134	129,238
Accounts Payable	7,473	7,060	6,815	4,746	6,911	6,071
Accrued Expenses	854.21	845.07	864.38	784.18	647.39	627.36
Short-Term Debt	18,048	16,142	11,794	12,720	9,916	14,750
Current Portion of Long-Term Debt	19,657	18,384	12,629	8,590	8,205	5,436
Current Portion of Leases	161.49	76.79	132.21	116.44	71.6	146.54
Current Income Taxes Payable	234.58	169.82	186.45	-	1,678	-
Current Unearned Revenue	-	-	-	-	-	57.69
Other Current Liabilities	11,396	9,042	9,907	6,962	6,954	7,694
Total Current Liabilities	57,824	51,720	42,327	33,919	34,382	34,782
Long-Term Debt	5,327	9,843	18,865	24,676	26,857	33,310
Long-Term Leases	150.62	59.01	61.44	133.54	127.43	217.73
Long-Term Unearned Revenue	-	-	-	-	-	3,142
Long-Term Deferred Tax Liabilities	-	-	-	-	-	1,046
Other Long-Term Liabilities	711.51	335.37	313.31	580.1	210	210
Total Liabilities	64,013	62,319	61,682	59,507	62,086	72,867
Common Stock	7,585	7,585	7,585	7,585	7,585	7,585
Additional Paid-In Capital	14,450	14,450	14,450	14,450	14,450	14,450
Retained Earnings	44,228	41,019	37,478	32,890	34,150	34,336
Comprehensive Income & Other	-760.26	-759.18	184.15	1.31	9.58	-9.05
Total Common Equity	65,503	62,295	59,698	54,927	56,195	56,363
Minority Interest	-286.54	-204.62	-166.81	-126.43	-147.38	7.8
Shareholders' Equity	65,217	62,090	59,531	54,800	56,048	56,371
Total Liabilities & Equity	129,229	124,409	121,213	114,307	118,134	129,238
Total Debt	43,344	44,505	43,481	46,236	45,177	53,860
Net Cash (Debt)	-40,272	-44,158	-41,241	-45,437	-42,673	-52,450
Net Cash Per Share	-2654.64	-2910.81	-2718.51	-2995.06	-2812.89	-3457.39
Filing Date Shares Outstanding	15.17	15.17	15.17	15.17	15.17	15.17
Total Common Shares Outstanding	15.17	15.17	15.17	15.17	15.17	15.17
Working Capital	-3,755	-4,612	2,720	2,548	5,297	9,807
Book Value Per Share	4317.80	4106.33	3935.14	3620.62	3704.24	3715.31
Tangible Book Value	64,926	61,709	59,106	54,428	55,696	55,778
Tangible Book Value Per Share	4279.77	4067.68	3896.09	3587.73	3671.34	3676.71
Land	13,944	13,944	13,860	13,722	13,722	11,837
Buildings	44,392	44,264	44,093	43,922	43,138	3,915
Machinery	33,182	32,628	27,545	26,864	25,014	15,015
Construction In Progress	-	-	-	-	-	63,863

Source: S&P Capital IQ. Standard template. Financial Sources.